(28)Commission Implementing Regulation (EU) 2023/918note extended the approval periods of the active substances fluoxastrobin, pirimiphos-methyl and propamocarb until 15 June 2025, and the approval period of the active substance prothioconazole until 15 August 2025.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.